# The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT

> **NCT07162792** · NA · NOT_YET_RECRUITING · sponsor: **Xuzhou Third People's Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Coronary Artery Disease(CAD)
- de Novo Coronary Lesions

## Interventions

- **DEVICE:** bioresorbable scaffold
- **DEVICE:** drug-coated balloon

## Key facts

- **NCT ID:** NCT07162792
- **Lead sponsor:** Xuzhou Third People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-23
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162792, "The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07162792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*